Consensus Core Laboratories Inc.

Stocks

CLB

US21867A1051

Business Support Services

Market Closed - NYSE 02:30:02 06/11/2026 am IST			5-day change	1st Jan Change
8.930 ^USD	-7.46%		-14.13%	-44.29%

29/10	Core Laboratories Inc., Q3 2026 Earnings Call, Oct 29, 2026
29/10	Core Laboratories Inc. Provides Earnings Guidance for the Fourth Quarter of 2026	CI

Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

bfee7d323fc.qo8h554rI9N5LDzTRfQEiPeKkzcoIr6XuTSv02O5crc.4_ttuMsbEbcmFHfrGoVCxprC9XUdc83a1WvJsjaLRsCe1Re0wWh5vS9tVw~228cc64dd91c568b0127575782026569

Analysts' recommendations: Core Laboratories Inc.

15/07	BofA Securities Adjusts Core Laboratories Price Target to $11 From $12	MT
12/25/12	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15	MT
06/25/06	Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating	MT
25/24/25	The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18	MT
25/24/25	Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18	MT
15/24/15	Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating	MT
29/24/29	Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	MT
18/23/18	Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	MT
31/23/31	Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	MT
30/23/30	Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	MT
01/23/01	Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	MT
01/23/01	Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	MT
28/23/28	Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	MT
18/23/18	BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	MT
07/23/07	Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	MT
09/23/09	BofA Securities Upgrades Core Laboratories to Neutral From Underperform	MT
07/22/07	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	MT
26/22/26	Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	MT
02/22/02	Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	MT
01/22/01	Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	MT
15/22/15	BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	MT
13/22/13	Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	MT
13/22/13	Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	MT
02/22/02	Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	MT
18/22/18	Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	MT

More recommendations

Testing Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CORE LABORATORIES INC.					+55.44%
	VISA, INC.					+1.57%
	CINTAS CORPORATION					-4.62%
	UNITED RENTALS, INC.					+15.1%
	PAYPAL HOLDINGS, INC.					-5.6%
	BLOCK, INC.					+11.73%
	NEBIUS GROUP					+98.56%
	SUNBELT RENTALS HOLDINGS, INC.					+10.2%
	FISERV, INC.					-4.73%
	CORPAY, INC.					+10.05%
	Average					+18.77%
	Weighted average by Cap.					+5.43%